Christensen Jamie

Jamie Christensen serves as the Executive Vice President and Chief Scientific Officer at Mirati Therapeutics, Inc., a company focused on developing innovative therapies for cancer treatment. His recent trading activity, as disclosed in SEC Form 4 filings, reveals a pattern of sale activity, with a total of 17 disclosures recorded from December 19, 2023, to January 23, 2024. Notably, the largest reported transaction involved a sale valued at approximately $3.8 million, highlighting significant movements within the healthcare sector.